Yuhan Corporation
000100
Kedudukan dalam Saham
#3833
Yuhan Corporation, a prominent South Korean pharmaceutical firm established in... Yuhan Corporation, a prominent South Korean pharmaceutical firm established in 1926 and headquartered in Seoul, specializes in the research, development, and manufacture of active pharmaceutical ingredients (APIs) and intermediates for both domestic and international markets. Its extensive product portfolio encompasses a wide array of prescription pharmaceuticals (ETC), addressing therapeutic areas such as cardiovascular, alimentary, genito-urinary, metabolic, respiratory, allergy, and neurological systems, alongside anti-infectives, anti-cancer treatments, and hormonal therapies. Notable offerings include Revanex, an acid pump antagonist designed for treating peptic ulcers and gastritis-related mucosal injury. Beyond prescription drugs, Yuhan Corporation provides a diverse range of over-the-counter (OTC) medications, including vitamins, mineral supplements, hepatopathy treatments, tonics, and drugs for respiratory, alimentary, dermatological, and pain relief applications. The company also extends its reach into consumer health and household goods, producing items like bleaches, detergents, pesticides, and oral care products. Further diversifying its operations, Yuhan is involved in the dental sector, supplying implants, equipment, consumables, and dental care solutions, and manufactures veterinary medical supplies for livestock, aquatic species, and companion animals. Additionally, it offers contract manufacturing services to other businesses.
Harga Saham
$63.22
Modal Pasaran
$4.27B
Perubahan (1 hari)
-3.12%
Perubahan (1 tahun)
-23.57%
Negara
KR
Perdagangan Yuhan Corporation (000100)
Kategori
Healthcare
EPS untuk Yuhan Corporation (000100)
EPS setakat June 2026 TTM: $2.15
Menurut laporan kewangan terkini dan harga saham Yuhan Corporation, EPS semasa syarikat (TTM) adalah $2.15. Pada akhir tahun 2024, syarikat mempunyai EPS sebanyak $0.64 penurunan berbanding EPS tahun 2023 iaitu $1.40.
Sejarah EPS untuk Yuhan Corporation dari 2007 hingga 2026
EPS pada akhir setiap tahun
| Tahun | EPS | Ubah |
|---|---|---|
| 2026 (TTM) | $2.15 | 19.67% |
| 2025 | $1.80 | 180.50% |
| 2024 | $0.64 | -54.28% |
| 2023 | $1.40 | 46.71% |
| 2022 | $0.96 | -16.23% |
| 2021 | $1.14 | -51.31% |
| 2020 | $2.34 | 388.80% |
| 2019 | $0.48 | -35.81% |
| 2018 | $0.75 | -50.07% |
| 2017 | $1.50 | -23.02% |
| 2016 | $1.94 | 31.02% |
| 2015 | $1.48 | 29.97% |
| 2014 | $1.14 | 2.35% |
| 2013 | $1.12 | 8.26% |
| 2012 | $1.03 | -3.46% |
| 2011 | $1.07 | -27.24% |
| 2010 | $1.47 | 10.23% |
| 2009 | $1.33 | 5.12% |
| 2008 | $1.27 | 1.26% |
| 2007 | $1.25 | 0.00% |
EPS untuk syarikat atau pesaing yang serupa
| Syarikat | EPS | Perbezaan EPS | Negara |
|---|---|---|---|
| $6.55 | 203.94% |
DE
|
|
| $6.12 | 184.13% |
DE
|
|
| $0.72 | -66.43% |
JP
|
|
| $3.66 | 69.91% |
CH
|
|
| $0.53 | -75.22% |
IN
|
